Notice of Extraordinary General Meeting 2026 in Qlife Holding AB - Resolution on change of auditing firm
The shareholders of Qlife Holding AB, company registration number 559224-8040, are hereby invited to attend an Extraordinary General Meeting on 7 October 2026 at 11:00 a.m. at the offices of Moll Wendén at Stortorget 8 in Malmö.
Right to attend and registration
Those who wish to participate in the meeting must:
- be listed as a shareholder in the share register prepared by Euroclear Sweden AB regarding the circumstances as per the record date of 29 September 2026,
- give notice of intent to participate no later than 1 October 2026. Notification shall be made either by post to Moll Wendén Law AB, Extraordinary General Meeting, Stortorget 8, 211 34 Malmö, Sweden, or by email to QlifeEGM@mollwenden.se.
The notification must state the full name, personal or company registration number, shareholding, address, daytime telephone number and, where applicable, information about representatives, proxies and assistants. The number of assistants may not exceed two (2). Where applicable, the notification should be accompanied by proxies, registration certificates and other authorisation documents.
In order to be entitled to participate in the meeting, a shareholder whose shares are registered in the name of a nominee must, in addition to giving notice of participation in the general meeting, register its shares in its own name at Euroclear Sweden AB so that the shareholder is listed in the share register as of the record date of 29 September 2026. Such re-registration may be temporary (so-called voting rights registration), and a request for such voting rights registration shall be made to the nominee, in accordance with the nominee's routines, at such time in advance as decided by the nominee. Voting rights registration that has been made by the nominee no later than the second banking day after 29 September 2026 will be taken into account in the presentation of the share register.
Proxies, etc.
If a shareholder is to be represented by a proxy, the proxy must bring a written, dated and signed proxy form to the extraordinary general meeting. The proxy form may not be older than one year, unless a longer period of validity (but no longer than five (5) years) has been specified in the proxy form. If the power of attorney has been issued by a legal entity, the proxy must also bring a current certificate of registration or equivalent authorisation document for the legal entity. To facilitate admission, a copy of the proxy and other authorisation documents should be enclosed with the notification of attendance at the extraordinary general meeting. Proxy forms will be available on the company's website (www.qlifeholding.com) and will be sent by post to shareholders who contact the company and provide their address.
Proposed agenda
- Opening of the meeting.
- Election of chairperson of the meeting.
- Preparation and approval of the voting list.
- Approval of the agenda.
- Election of one or two persons to verify the minutes.
- Determination of whether the meeting has been duly convened.
- Resolution on change of auditor.
- Closing of the meeting.
Proposed resolutions
Item 2 : Election of chairperson of the meeting
The board of directors proposes that Henric Stråth, Moll Wendén, or, in his absence, the person appointed by the board of directors, be elected as chairperson of the meeting.
Item 7: Resolution on change of auditor
The board of directors proposes that the general meeting resolve to elect the registered audit firm Grant Thornton Sweden AB, reg. no. 556356-9382, as the company’s auditor for the period until the end of the next annual general meeting. Grant Thornton Sweden AB has announced that authorised public accountant Mattias Olofson will continue to serve as the auditor-in-charge.
Information at the extraordinary general meeting
Shareholders present at the extraordinary general meeting are entitled to request information in accordance with Chapter 7, Section 32, Paragraph 1, Item 1 of the Swedish Companies Act (2005:551).
Available documents
Complete proposals for resolutions and other documents to be provided prior to the extraordinary general meeting in accordance with the Swedish Companies Act will be made available at the company and on the company's website, www.qlifeholding.com, at least two (2) weeks prior to the date of the extraordinary general meeting and will be sent free of charge to shareholders who so request and provide their postal address. In other respects, the board's complete proposals for resolutions are set out in the notice. Copies of the documents will also be available at the meeting.
Processing of personal data
For information on how your personal data is processed, see https://www.euroclear.com/dam/ESw/Legal/Privacy-notice-bolagsstammor-engelska.pdf.
Shares and votes in the company
The total number of shares and votes in the company as of the date of the notice of the meeting is 28,874,177. The company does not hold any shares.
__________
Gothenburg, September 2026
Qlife Holding AB (publ)
The Board of Directors
For further information, please contact:
Thomas Warthoe
Chief Executive Officer (CEO)
Phone: +45 21 63 35 34
Email tw@egoo.health
About Qlife
Qlife is a Swedish company based in Göteborg, which develops and markets an innovative medical technology platform, Egoo.Health ("Egoo"), with the goal of giving people access to clinical biomarker data when testing at home. The company is listed on the Nasdaq First North Growth Market (ticker: QLIFE). G&W Fondkommission is the Company's Certified Adviser. For additional information, please visit www.qlifeholding.com.
Read more at Egoo.health, Qlifeholding.com or follow us on LinkedIn.